Skip to content

ADHD: Medication or Meditation?

ADHD: Medication or Meditation? - My child has ADHD: Meditation or Medication?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON44743
Enrollment
150
Registered
2014-01-17
Start date
2014-05-22
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD (Attention Deficit Hyperactivity Disorder)

Interventions

The mindfulness training for children consists of 8-9 weekly group meetings of 1.5 hours. Parallel to this parents participate in the weekly Mindful Parenting training which also takes 1.5 hours eac

Sponsors

Universiteit van Amsterdam
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: - The child is between 9 and 18 years of age (also turning 9 during time of study) - The child has a primary DSM classification of ADHD - ADHD is verified by standardized structured DSM interview - (Estimated) IQ is over 80 - At least one parent is willing to participate in the Mindful Parenting training

Exclusion criteria

Exclusion criteria: - (Estimated) IQ is below 80 - Suicidal risk - Suffering from psychosis, schizophrenia, or untreated PTSD - Co morbid conduct problems that are so severe, already during intake, that interaction/talking between parent and child is not possible. - Current or previous use of methylphenidate in the past month - Current or previous participation in mindfulness training in the past month - Participation in a currently active other psychological intervention

Design outcomes

Primary

MeasureTime frame
Attention problems (also hyperactivity and impulsivity) as reported by the parents, child, teacher, and test observer.

Secondary

MeasureTime frame
Symptoms of anxiety, depression, social functioning, stress, tiredness and quality of life.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)